Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema

Genes to Cells

Volumn 10, Issue 12, 2005, Pages 1113-1125

  Iizuka, Takashi ^a   Ishii, Yukio ^a   Itoh, Ken ^a   Kiwamoto, Takumi ^a   Kimura, Toru ^a   Matsuno, Yosuke ^a   Morishima, Yuko ^a   Hegab, Ahmed E ^a   Homma, Shinsuke ^a   Nomura, Akihiro ^a   Sakamoto, Tohru ^a   Shimura, Masako ^b   Yoshida, Aruto ^b   Yamamoto, Masayuki ^a   Sekizawa, Kiyohisa ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b KIRIN BREWERY CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CIGARETTE SMOKE; LEUKOCYTE ELASTASE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ENZYME ACTIVITY; EXPOSURE; GENE EXPRESSION; HISTOPATHOLOGY; KNOCKOUT MOUSE; LUNG EMPHYSEMA; LUNG INJURY; LUNG LAVAGE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; OBSERVATION; PNEUMONIA; PRIORITY JOURNAL; REGULATORY MECHANISM; WILD TYPE;

ANIMALS; ANTIOXIDANTS; BRONCHOALVEOLAR LAVAGE FLUID; GENETIC PREDISPOSITION TO DISEASE; LEUKOCYTE ELASTASE; LUNG; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEUTROPHILS; NF-E2-RELATED FACTOR 2; PHAGOCYTOSIS; PNEUMONIA; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; PULMONARY EMPHYSEMA; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; TOBACCO SMOKE POLLUTION;

ANIMALIA;

EID: 29244473882     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2005.00905.x     Document Type: Article

References (47)

1. Abbinante-Nissen, J.M., Simpson, L.G. & Leikauf, G.D. (1993) Neutrophil elastase increases secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am. J. Physiol. 265, L286-L292.
2. Asada, K., Sasaki, S., Suda, T., Chida, K. & Nakamura, H. (2004) Antiinflammatory roles of peroxisome proliferator-activated receptor gamma in human alveolar macrophages. Am. J. Respir. Crit. Care Med. 169, 195-200.
3. Barnes, P.J. (2000) Chronic obstructive pulmonary disease. New Engl. J. Med. 343, 269-280.
4. Betsuyasu, T., Takeyabu, K., Tanino, M. & Nishimura, M. (2002) Role of secretory leukocyte protease inhibitor in the development of subclinical emphysema. Eur. Respir. J. 19, 1051-1057.
5. Chan, K. & Kan, Y.W. (1999) Nrf2 is essential for protection against acute pulmonary injury in mice. Proc. Natl. Acad. Sci. USA 96, 12731-12736.
6. Cho, H.Y., Jedlicka, A.E., Reddy, S.P., et al. (2002) Role of NRF2 in protection against hyperoxic lung injury in mice. Am. J. Respir. Cell Mol. Biol. 26, 175-182.
7. Czermak, B.J., Sarma, V., Bless, N.M., Schmal, H., Friedl, H.P. & Ward, P.A. (1999) In vitro and in vivo dependency of chemokine generation on C5a and TNF-a. J. Immunol. 162, 2321-2325.
8. Dietz, A.A., Rubinstein, H.M. & Hodges, L.V. (1974) Measurement of alpha1-antitrypsin in serum, by immunodiffusion and by enzymatic assay. Clin. Chem. 20, 396-399.
9. Driscoll, K.E. (1994) Macrophage inflammatory proteins: biology and role in pulmonary inflammation. Exp. Lung Res. 20, 473-490.
10. Hautamaki, R.D., Kobayashi, D.K., Senior, R.M. & Shapiro, S.D. (1997) Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277, 2002-2004.
11. Hubbard, R.C. & Crystal, R.G. (1991) Antiproteases. In: The Lung: Scientific Foundations (eds R.G. Crystal,J.B. West & P.J. Barnes), pp. 1775-1787. New York, NY: Raven Press.
12. Ishii, T., Itoh, K., Ruiz, E., et al. (2004) Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ. Res. 94, 609-616.
13. Ishii, T., Itoh, K., Takahashi, S., et al. (2000) Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 275, 16023-16029.
14. Ishii, T., Itoh, K. & Yamamoto, M. (2002) Roles of Nrf2 in activation of antioxidant enzyme genes via antioxidant responsive elements. Methods Enzymol. 348, 182-190.
15. Itoh, K., Chiba, T., Takahashi, S., et al. (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236, 313-322.
16. 2. Mol. Cell. Biol. 24, 36-45.
17. Jin, F.Y., Nathan, C., Radzioch, D. & Ding, A. (1997) Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 88, 417-426.
18. Kramps, J.A., Rudolphus, A., Stolk, J., Willems, L.N. & Dijkman, J.H. (1991.) Role of antileukoprotease in the human lung. Ann. NY Acad. Sci. 624, 97-108.
19. Laborda, J. (1991) 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res. 19, 3998.
20. Lentsch, A.B., Jordan, J.A., Czermak, B.J., et al. (1999) Inhibition of NF-κB activation and augmentation of IκBβ by secretory leukocyte protease inhibitor during lung inflammation. Am. J. Pathol. 154, 239-247.
21. Lin, A.L., Johnson, D.A., Stephan, K.T. & Yeh, C.K. (2004) Salivary secretory leukocyte protease inhibitor increases in HIV infection. J. Oral Pathol. Med. 33, 410-416.
22. Lucey, E.C., Stone, P.J., Ciccolella, D.E., et al. (1990) Recombinant human secretory leukocyte-protease inhibitor: in vitro properties, and amelioration of human neutrophil elastase-induced emphysema and secretory cell metaplasia in the hamster. J. Lab. Clin. Med. 115, 224-232.
23. MacNee, W. & Rahman, I. (1999) Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160, S58-S65.
24. MacNee, W. & Rahman, I. (2001) Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease? Trends Mol. Med. 7, 55-62.
25. March, T.H., Barr, E.B., Finch, G.L., et al. (1999) Cigarette smoke exposure produces more evidence of emphysema in B6C3F1 mice than in F344 rats. Toxicol. Sci. 51, 289-299.
26. McElvaney, N.G. & Crystal, R.G. (1997) Inherited susceptibility of the lung to proteolytic injury. In: The Lung: Scientific Foundations (eds R.G. Crystal, J.B. West, E.R. Weibel & P.J. Barnes), pp. 2537-2553. Philadelphia, PA: Lippincott-Raven.
27. Ming, W.J., Bersani, L. & Mantovani, J.E. (1987) Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J. Immunol. 138, 1469-1474.
28. Murray, C.J.L. & Lopez, A.D. (1996) Evidence-based health policy-lessons from the Global Burden of Disease Study. Science 274, 740-743.
29. Nagai, A., Inano, H., Matsuba, K. & Thurlbeck, W.M. (1994) Scanning electronmicroscopic morphometry of emphysema in humans. Am. J. Respir. Crit. Care Med. 150, 1411-1415.
30. Nakamura, A., Mori, Y., Hagiwara, K., et al. (2003) Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice. J. Exp. Med. 197, 669-674.
31. Pryor, W.A. & Stone, K. (1993) Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann. NY. Acad. Sci. 686, 12-28.
32. Rangasamy, T., Cho, C.Y., Thimmulappa, R.K., et al. (2004) Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J. Clin. Invest. 114, 1248-1259.
33. Repine, J.E., Bast, A. & Lankhorst, I. (1997) Oxidative stress in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 156, 341-357.
34. Rudolphus, A., Kramps, J.A. & Dijkman, J.H. (1991) Effect of human antileucoprotease on experimental emphysema. Eur. Respir. J. 4, 31-39.
35. Saetta, M., Shiner, R.J., Angus, G.E., et al. (1985) Destructive index: a measurement of lung parenchymal destruction in smokers. Am. Rev. Respir. Dis. 131, 764-769.
36. Sakamaki, F., Ishizaka, A., Urano, T., et al. (1996) Effect of a specific neutrophil elastase inhibitor, ONO-5046, on endotoxin-induced acute lung injury. Am. J. Respir. Crit. Care Med. 153, 391-397.
37. Sallenave, J.M., Shulmann, J., Crossley, J., Jordana, M. & Gauldie, J. (1994) Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am. J. Respir. Cell Mol. Biol. 11, 733-741.
38. Shapiro, S.D., Goldstein, N.M., Houghton, A.M., Kobayashi, D.K., Kelley, D. & Belaaouaj, A. (2003) Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am. J. Pathol. 163, 2329-2335.
39. Siafakas, N.M. & Tzortzaki, E.G. (2002) Few smokers develop COPD. Why? Respir. Med. 96, 615-624.
40. Smith, S.F., Guz, A., Burton, G.H., Cooke, N.T. & Tetley, T.D. (1986) Acid-stable low molecular mass proteinase inhibitors in human lung lavage. Biol. Chem. Hoppe. Seyler. 367, 183-189.
41. Smith, C.E. & Johnson, D.A. (1985) Human bronchial leucocyte proteinase inhibitor. Rapid isolation and kinetic analysis with human leucocyte proteinases. Biochem. J. 225, 463-472.
42. Snider, G.L. (1992) Emphysema: the first two centuries - and beyond. A historical overview, with suggestions for future research: part 1. Am. Rev. Respir. Dis. 146, 1334-1344.
43. Strider, R.M., Chensue, S.W., Basha, M.A., et al. (1990) Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor, lipopolysaccharide, and interleukin 1. Am. J. Respir. Cell Mol. Biol. 2, 321-326.
44. Tirumalai, R., Kumar, T.R., Mai, K.H. & Biswal, S. (2002) Acrolein causes transcriptional induction of phase II genes by activation of Nrf2 in human lung type II epithelial (A549) cells. Toxicol. Lett. 132, 27-36.
45. Turino, G.M. (2002) The origins of a concept: the protease anti-protease imbalance hypothesis. Chest 122, 1058-1060.
46. Turino, G.M., Senior, R.M., Garg, B.D., Keller, S., Levi, M.M. & Mandl, I. (1969) Serum elastase inhibitor deficiency and alpha 1-antitrypsin deficiency in patients with obstructive emphysema. Science 165, 709-711.
47. Viegi, G., Scognamiglio, A., Baldacci, S., Pistelli, F. & Carrozzi, L. (2001) Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration 68, 4-19.